Elevated plasma neurofilament light in aging reflects brain white‐matter alterations but does not predict cognitive decline or Alzheimer's disease-Reference-Cited by-同舟云学术

Elevated plasma neurofilament light in aging reflects brain white‐matter alterations but does not predict cognitive decline or Alzheimer's disease

Published:2020-01 Issue:1 Volume:12 Page:
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Nyberg Lars¹²³,Lundquist Anders³⁴⁵,Nordin Adolfsson Annelie⁶,Andersson Micael²³,Zetterberg Henrik⁷⁸⁹¹⁰,Blennow Kaj⁷⁸,Adolfsson Rolf⁶

Affiliation:

1. Department of Radiation Sciences Umeå University Umeå Sweden

2. Department of Integrative Medical Biology Umeå University Umeå Sweden

3. Umeå Center for Functional Brain Imaging (UFBI) Umeå University Umeå Sweden

4. Department of Statistics USBE Umeå University Umeå Sweden

5. Swedish University of Agricultural Sciences Umeå Umeå Sweden

6. Department of Clinical Sciences Umeå University Umeå Sweden

7. Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology The Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

8. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

9. Department of Neurodegenerative Disease UCL Institute of Neurology London UK

10. UK Dementia Research Institute at UCL London UK

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dad2.12050

Reference30 articles.

1. Plasma Amyloid‐β as a predictor of dementia and cognitive decline;Koyama A;Arch Neurol,2012

2. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers;Hanon O;Alzheimers Dement (Amst),2018